Blomberg, O. S., Kos, K., Spagnuolo, L., Isaeva, O. I., Garner, H., Wellenstein, M. D., . . . de Visser, K. E. (2023). Neoadjuvant immune checkpoint blockade triggers persistent and systemic Treg activation which blunts therapeutic efficacy against metastatic spread of breast tumors. Oncoimmunology, 12(1), 2201147. https://doi.org/10.1080/2162402X.2023.2201147
Chicago-Zitierstil (17. Ausg.)Blomberg, Olga S., et al. "Neoadjuvant Immune Checkpoint Blockade Triggers Persistent and Systemic Treg Activation Which Blunts Therapeutic Efficacy Against Metastatic Spread of Breast Tumors." Oncoimmunology 12, no. 1 (2023): 2201147. https://doi.org/10.1080/2162402X.2023.2201147.
MLA-Zitierstil (9. Ausg.)Blomberg, Olga S., et al. "Neoadjuvant Immune Checkpoint Blockade Triggers Persistent and Systemic Treg Activation Which Blunts Therapeutic Efficacy Against Metastatic Spread of Breast Tumors." Oncoimmunology, vol. 12, no. 1, 2023, p. 2201147, https://doi.org/10.1080/2162402X.2023.2201147.